Our TCGA analysis demonstrated that several in vitro METRO-TOPO gene signatures including SERPINB5, MMP9, and FOS were correlated with patient survival and varied significantly (p < 0.05) between AA vs EA PCa patients. The gene discussed is FOS; the disease is posterior cortical atrophy.